|
Name |
4-Hydroxyvalproic acid
|
Molecular Formula | C8H16O3 | |
IUPAC Name* |
4-hydroxy-2-propylpentanoic acid
|
|
SMILES |
CCCC(CC(C)O)C(=O)O
|
|
InChI |
InChI=1S/C8H16O3/c1-3-4-7(8(10)11)5-6(2)9/h6-7,9H,3-5H2,1-2H3,(H,10,11)
|
|
InChIKey |
OASKNPCLIHUTTL-UHFFFAOYSA-N
|
|
Synonyms |
4-Hydroxyvalproic acid; 4-Hydroxy-2-propylpentanoic acid; 4-OH-Vpa; 60113-82-8; 2-Propyl-4-hydroxypentanoic acid; 2-n-Propyl-4-hydroxypentanoic acid; 4-Hydroxyvalproate; 4-Hydroxy-valproate; SCHEMBL2386631; CHEMBL3706504; CHEBI:80635; DTXSID20975544; LMFA01050496; Pentanoic acid, 4-hydroxy-2-propyl-; AKOS006276329; Q27149681
|
|
CAS | 60113-82-8 | |
PubChem CID | 134467 | |
ChEMBL ID | CHEMBL3706504 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 160.21 | ALogp: | 1.3 |
HBD: | 2 | HBA: | 3 |
Rotatable Bonds: | 5 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 57.5 | Aromatic Rings: | 0 |
Heavy Atoms: | 11 | QED Weighted: | 0.644 |
Caco-2 Permeability: | -4.883 | MDCK Permeability: | 0.00244920 |
Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.037 |
Human Intestinal Absorption (HIA): | 0.024 | 20% Bioavailability (F20%): | 0.002 |
30% Bioavailability (F30%): | 0.048 |
Blood-Brain-Barrier Penetration (BBB): | 0.949 | Plasma Protein Binding (PPB): | 31.78% |
Volume Distribution (VD): | 0.426 | Fu: | 57.23% |
CYP1A2-inhibitor: | 0.025 | CYP1A2-substrate: | 0.163 |
CYP2C19-inhibitor: | 0.028 | CYP2C19-substrate: | 0.466 |
CYP2C9-inhibitor: | 0.005 | CYP2C9-substrate: | 0.946 |
CYP2D6-inhibitor: | 0.007 | CYP2D6-substrate: | 0.256 |
CYP3A4-inhibitor: | 0.008 | CYP3A4-substrate: | 0.048 |
Clearance (CL): | 8.624 | Half-life (T1/2): | 0.812 |
hERG Blockers: | 0.012 | Human Hepatotoxicity (H-HT): | 0.12 |
Drug-inuced Liver Injury (DILI): | 0.03 | AMES Toxicity: | 0.008 |
Rat Oral Acute Toxicity: | 0.025 | Maximum Recommended Daily Dose: | 0.017 |
Skin Sensitization: | 0.191 | Carcinogencity: | 0.068 |
Eye Corrosion: | 0.952 | Eye Irritation: | 0.989 |
Respiratory Toxicity: | 0.078 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000889 | 0.514 | D0Y3KG | 0.543 | ||||
ENC000306 | 0.459 | D08QGD | 0.355 | ||||
ENC001004 | 0.385 | D00WUF | 0.333 | ||||
ENC000824 | 0.382 | D03LGY | 0.328 | ||||
ENC000550 | 0.378 | D09PUL | 0.281 | ||||
ENC000037 | 0.367 | D01OPV | 0.275 | ||||
ENC000289 | 0.364 | D00ENY | 0.262 | ||||
ENC000031 | 0.364 | D02UDJ | 0.250 | ||||
ENC005934 | 0.358 | D07SJT | 0.245 | ||||
ENC005374 | 0.354 | D07WXE | 0.245 |